1 completed, 1 recruiting. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 2 | Completed 1, Recruiting 1 |
Follow Fampridine: new trials by email Literature Review of Fampridine trials Research Report on Fampridine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 4-aminopyridine Treatment for Nerve Injury 4-Aminopyridine, Placebo - Nerve Injury, Prostate Cancer | Phase 2 / Phase 3 | Recruiting | John Elfar | 70 | 2021-06-05 | 2025-12-17 |
| Ampyra for Optic Neuritis in Multiple Sclerosis Dalfampridine/Placebo, Placebo/Dalfampridine - Multiple Sclerosis, Optic Neuritis | Phase 2 / Phase 3 | Completed | Washington University School of Medicine | 53 | 2011-05-01 | 2020-01-30 |
Erectile Dysfunction (1) · Multiple Sclerosis (1) · Optic Neuritis (1) · Prostatic Neoplasms (1)
John Elfar (1) · Washington University School of Medicine (1)
United States (2)
John Elfar, MD (1) · Rashid Sayyid, MD (1) · Robert T Naismith, MD (1)